Continuous Renal Replacement Therapy Market

Continuous Renal Replacement Therapy Market (Mode: Slow Continuous Ultrafiltration, Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, and Continuous Venovenous Hemodiafiltration) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Continuous Renal Replacement Therapy Market Outlook 2031

  • The global industry was valued at US$ 1.2 Bn in 2021
  • It is projected to grow at a CAGR of 7.5% from 2022 to 2031 and reach more than US$ 2.5 Bn by the end of 2031

Analysts’ Viewpoint

Incorporation of nanotechnology, sorbent-based techniques, and water-saving strategies is the key trend in the continuous renal replacement therapy (CRRT) ecosystem. Nanotechnology is anticipated to enhance the portability of future devices. Rise in acute kidney injury diseases, increase in patient pool, advancements in technology, surge in geriatric population, growth in investments, and surge in number of dialysis centers are likely to fuel market development.

Technological advances in continuous renal replacement therapies is likely to present significant opportunities for market expansion in the next few years. Constant need for effective follow-up among patients has induced manufacturers to develop innovative artificial intelligence (AI) technology and sensors, which can be used in ICUs to predict which patients are at high risk of imminent deterioration.

Continuous Renal Replacement Therapy Market

Continuous Renal Replacement Therapy Market Introduction

CRRT is a preferred modality for managing the hemodynamic status of patients suffering from acute kidney injury. Patients with acute renal failure and those experiencing complications, such as imperfections or multiple organ failure in their circulatory systems that include edema and cardiac insufficiency, are also treated using CRRT systems. Other complications where these systems are used include postoperative liver failure, fulminant hepatitis, serve acute pancreatitis, and multiple organ failure.

Request a sample to get extensive insights into the Continuous Renal Replacement Therapy Market

Rise in Prevalence of Chronic Kidney Disease (CKD) to Drive Industry Progress

The global continuous renal replacement therapy market size is driven by the increase in global geriatric population. This population is more prone to chronic diseases such as chronic kidney disease (CKD). According to the United Nations (UN), the global geriatric population (65 years or above) stood at 703 million in 2019. The number is projected to double to reach 1.5 billion by 2050. According to estimates from researchers at Johns Hopkins University, more than 50% of individuals over the age of 75 are believed to be afflicted with kidney disease. Kidney disease has also been found to be more prevalent in people over the age of 60 compared to the rest of the general population.

According to Centers for Disease Control and Prevention (CDC) estimates, CKD is more common in individuals aged 65 years or older (38%) than in people aged 45–64 years (12%) or 18–44 years (6%). CKD is slightly more common in women (14%) than men (12%). The CDC stated that more than one in seven (15%) of the U.S. adults, or 37 million patients, are estimated to have CKD currently.

Chronic kidney disease has been recognized as a leading public health issue worldwide. The global estimated prevalence of CKD is 13.4% (11.7%–15.1%), and patients with end-stage kidney disease (ESKD) needing renal replacement therapy are estimated between 4.90 million and 7.08 million. The global prevalence of CKD stood at 9.1%, which was about 700 million cases, in 2017. CKD is a major public health issue in low- and middle-income countries (LMICs). Its prevalence has been rapidly increasing in LMICs, particularly in Asia.

Increase in Number of Dialysis Centers Fueling Continuous Renal Replacement Therapy Market

Rise in number of dialysis centers is likely to drive the global continuous renal replacement therapy business during the forecast period. Growth in the market can be ascribed to the rise in prevalence of acute kidney injury (AKI), presence of large number of hospitals in the U.S., and well-developed healthcare infrastructure.

Fresenius Medical Care owned and managed around 3,928 dialysis clinics in 2018 as against 3,752 dialysis clinics in 2017. According to American Hospital Association, the U.S had 5,141 community hospitals, 625 nonfederal psychiatric hospitals, and 208 federal government hospitals in 2021.

According to the Centers for Disease Control and Prevention, nearly 786,000 people in the U.S. were living with end-stage renal disease (ESRD) in 2021, with 71% on dialysis and 29% with a kidney transplant. Thus, rise in prevalence of end-stage renal disease has led to an increase in number of dialysis clinics and treatment centers.

Leading players in the industry are undertaking initiatives to reach maximum ESRD patients across all regions by increasing the number of dialysis centers. For instance, B. Braun Melsungen AG alone has more than 300 centers in Europe, Africa, and Asia Pacific. On World Kidney Day on March 9, 2017, Fresenius Medical Care launched a brand new Asia Pacific-wide corporate social responsibility initiative through a series of public awareness events reaching 6,600 children, parents, and caretakers as well as media, key renal health partners, and governments.

Request a custom report on Continuous Renal Replacement Therapy Market

Growth in Application Augmenting Continuous Venovenous Hemofiltration Segment

In terms of mode, the global market has been classified into slow continuous ultrafiltration (SCUF), continuous venovenous haemofiltration (CVVH), continuous venovenous haemodialysis (CVVHD), and continuous venovenous haemodiafiltration (CVVHDF). The continuous venovenous haemofiltration segment held major share during the forecast period. CVVHD is a short term effective temporary treatment for patients suffering from acute or chronic renal failure.

According to an article published by the American Society of Nephrology in 2019, congestive heart failure, which accounts for around 8.0% of all-cause mortality in patients with CKD stages 4 and 5, is directly linked to fluid overload. This is likely to increase the usage of CVVH treatment.

High Volume Sales Bolstering Disposables Segment

Based on product, the global continuous renal replacement therapy market has been segregated into dialysate & replacement fluids, disposables, and systems. The disposables segment has been split into bloodline sets, hemofilters, and other disposables.

The disposables segment is likely to witness strong growth in the next few years, owing to high volume sales of disposables and optimal usage of bloodline sets, hemofilters, and tubing in continuous dialysis procedures. The hemofilters sub-segment held the largest share of the disposables segment in 2021. The trend is expected to continue in the near future.

Regional Analysis

As per continuous renal replacement therapy market trends, Europe is projected to account for a leading share during the forecast period owing to the increase in incidence of acute kidney injury and favorable reimbursement policies in the region. Presence of key players, well-established research & development infrastructure, and strong government funding for CRRT for critically ill patients are likely to be other major business catalysts in the region in the next few years.

The market in Asia Pacific is projected to expand at a rapid pace during the forecast period due to strong economic growth, rise in health care infrastructure, increase in geriatric population, and surge in investments for developing advanced CRRT products. Initiatives by local governments of countries to attain self-sufficiency in manufacturing renal replacement devices are likely to be key market catalysts in Middle East & Africa and Latin America.

Analysis of Key Players

This report provides profiles of leading players operating in the global continuous renal replacement therapy market. These include Baxter International, Inc., Nipro Corporation, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, B. Braun Melsungen AG, Medica SPA, INFOMED SA, Medtronic, and Toray Medical Company Limited (Toray Industries, Inc.). These players are focused on adopting organic and inorganic growth strategies to strengthen their product portfolio to improve patient healthcare. Companies are focusing on increasing their geographical footprint through mergers & acquisitions and investment in research & development activities in order to remain competitive in the business.

Key Developments in Continuous Renal Replacement Therapy Industry

  • In May 2021, Baxter International, Inc. announced the launch of PrisMax 2 worldwide, the most recent version of its next-generation platform. PrisMax 2 is developed to help hospitals meet the special demands of intensive care unit (ICU), while simplifying the transfer of organ support along with CRRT.
  • In February 2019, Fresenius Medical Care acquired NXStage Medical, Inc., a home dialysis product manufacturer

Leading players have been profiled in the market report based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.

Global Continuous Renal Replacement Therapy Market Snapshot

Attribute

Detail

Size in 2021

US$ 1.2 Bn

Forecast (Value) in 2031

More than US$ 2.5 Bn

Compound Annual Growth Rate (CAGR)

7.5%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Mode
    • Slow Continuous Ultrafiltration (SCUF)
    • Continuous Venovenous Hemofiltration (CVVHF)
    • Continuous Venovenous Hemodialysis (CVVHD)
    • Continuous Venovenous Hemodiafiltration (CVVHDF)
  • Product
    • Dialysate & Replacement Fluids
    • Disposables
    • Systems
  • Therapy
    • Renal
    • Non-renal
    • Combination
  • End-user
    • Hospitals
    • Clinics
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Baxter International, Inc.
  • Nipro Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Medica SPA
  • INFOMED SA
  • Medtronic
  • Toray Medical Company Limited (Toray Industries, Inc.)

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global continuous renal replacement therapy market in 2021?

The industry was valued at US$ 1.2 Bn in 2021

How big will the business be in 2031?

It is projected to reach more than US$ 2.5 Bn by 2031

What will be the CAGR during the forecast period?

The market is anticipated to grow at a CAGR of 7.5% from 2022 to 2031

Which are the prominent trends that affect sector growth?

Increase in incidence of acute kidney injury, rapidly aging population with increase in co-morbidities, rise in number of dialysis centers across the world, and shift in government focus toward providing better health care facilities

Who are the prominent players in the continuous renal replacement therapy industry?

Baxter International, Inc., Nipro Corporation, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, B. Braun Melsungen AG, Medica SPA, INFOMED SA, Medtronic, and Toray Medical Company Limited (Toray Industries, Inc.)

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Continuous Renal Replacement Therapy Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Market Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Continuous Renal Replacement Therapy Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Market Outlook

        5.1. Incidence of Acute Kidney Injury Across the Globe

        5.2. Rise in Prevalence of Diabetes and Hypertension

        5.3. Reimbursement Scenario by Region/globally

        5.4. Regulatory Scenario by Region/globally

        5.5. Recent Technological Developments in Continuous Renal Replacement Therapy

        5.6. Development of CRRT System for Pediatric Patients

        5.7. Key Mergers & Acquisitions

    6. Global Continuous Renal Replacement Therapy Market Analysis and Forecast, by Mode

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Mode, 2017–2031

            6.3.1. Slow Continuous Ultrafiltration (SCUF)

            6.3.2. Continuous Venovenous Hemofiltration (CVVHF)

            6.3.3. Continuous Venovenous Hemodialysis (CVVHD)

            6.3.4. Continuous Venovenous Hemodiafiltration (CVVHDF)

        6.4. Market Attractiveness Analysis, by Mode

    7. Global Continuous Renal Replacement Therapy Market Analysis and Forecast, by Product

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Product, 2017–2031

            7.3.1. Dialysate & Replacement Fluids

            7.3.2. Disposables

                7.3.2.1. Bloodline Sets

                7.3.2.2. Hemofilters

                7.3.2.3. Other Disposables

            7.3.3. Systems

        7.4. Market Attractiveness Analysis, by Product

    8. Global Continuous Renal Replacement Therapy Market Analysis and Forecast, by Therapy

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Therapy, 2017–2031

            8.3.1. Renal

            8.3.2. Non-renal

            8.3.3. Combination

        8.4. Market Attractiveness Analysis, by Therapy

    9. Global Continuous Renal Replacement Therapy Market Analysis and Forecast, by End-user

        9.1. Introduction & Definition

        9.2. Key Findings / Developments

        9.3. Market Value Forecast, by End-user, 2017–2031

            9.3.1. Hospitals

            9.3.2. Clinics

            9.3.3. Others

        9.4. Market Attractiveness Analysis, by End-user

    10. Global Continuous Renal Replacement Therapy Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Market Value Forecast, by Region

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness Analysis, by Region

    11. North America Continuous Renal Replacement Therapy Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Mode, 2017–2031

            11.2.1. Slow Continuous Ultrafiltration (SCUF)

            11.2.2. Continuous Venovenous Hemofiltration (CVVHF)

            11.2.3. Continuous Venovenous Hemodialysis (CVVHD)

            11.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)

        11.3. Market Value Forecast, by Product, 2017–2031

            11.3.1. Dialysate & Replacement Fluids

            11.3.2. Disposables

                11.3.2.1. Bloodline Sets

                11.3.2.2. Hemofilters

                11.3.2.3. Other Disposables

            11.3.3. Systems

        11.4. Market Value Forecast, by Therapy, 2017–2031

            11.4.1. Renal

            11.4.2. Non-renal

            11.4.3. Combination

        11.5. Market Value Forecast, by End-user, 2017–2031

            11.5.1. Hospitals

            11.5.2. Clinics

            11.5.3. Others

        11.6. Market Value Forecast, by Country, 2017–2031

            11.6.1. U.S.

            11.6.2. Canada

        11.7. Market Attractiveness Analysis

            11.7.1. By Mode

            11.7.2. By Product

            11.7.3. By Therapy

            11.7.4. By End-user

            11.7.5. By Country

    12. Europe Continuous Renal Replacement Therapy Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Mode, 2017–2031

            12.2.1. Slow Continuous Ultrafiltration (SCUF)

            12.2.2. Continuous Venovenous Hemofiltration (CVVHF)

            12.2.3. Continuous Venovenous Hemodialysis (CVVHD)

            12.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)

        12.3. Market Value Forecast, by Product, 2017–2031

            12.3.1. Dialysate & Replacement Fluids

            12.3.2. Disposables

                12.3.2.1. Bloodline Sets

                12.3.2.2. Hemofilters

                12.3.2.3. Other Disposables

            12.3.3. Systems

        12.4. Market Value Forecast, by Therapy, 2017–2031

            12.4.1. Renal

            12.4.2. Non-renal

            12.4.3. Combination

        12.5. Market Value Forecast, by End-user, 2017–2031

            12.5.1. Hospitals

            12.5.2. Clinics

            12.5.3. Others

        12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.6.1. Germany

            12.6.2. U.K.

            12.6.3. France

            12.6.4. Spain

            12.6.5. Italy

            12.6.6. Rest of Europe

        12.7. Market Attractiveness Analysis

            12.7.1. By Mode

            12.7.2. By Product

            12.7.3. By Therapy

            12.7.4. By End-user

            12.7.5. By Country/Sub-region

    13. Asia Pacific Continuous Renal Replacement Therapy Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Mode, 2017–2031

            13.2.1. Slow Continuous Ultrafiltration (SCUF)

            13.2.2. Continuous Venovenous Hemofiltration (CVVHF)

            13.2.3. Continuous Venovenous Hemodialysis (CVVHD)

            13.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)

        13.3. Market Value Forecast, by Product, 2017–2031

            13.3.1. Dialysate & Replacement Fluids

            13.3.2. Disposables

                13.3.2.1. Bloodline Sets

                13.3.2.2. Hemofilters

                13.3.2.3. Other Disposables

            13.3.3. Systems

        13.4. Market Value Forecast, by Therapy, 2017–2031

            13.4.1. Renal

            13.4.2. Non-renal

            13.4.3. Combination

        13.5. Market Value Forecast, by End-user, 2017–2031

            13.5.1. Hospitals

            13.5.2. Clinics

            13.5.3. Others

        13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.6.1. China

            13.6.2. Japan

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of Asia Pacific

        13.7. Market Attractiveness Analysis

            13.7.1. By Mode

            13.7.2. By Product

            13.7.3. By Therapy

            13.7.4. By End-user

            13.7.5. By Country/Sub-region

    14. Latin America Continuous Renal Replacement Therapy Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Mode, 2017–2031

            14.2.1. Slow Continuous Ultrafiltration (SCUF)

            14.2.2. Continuous Venovenous Hemofiltration (CVVHF)

            14.2.3. Continuous Venovenous Hemodialysis (CVVHD)

            14.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)

        14.3. Market Value Forecast, by Product, 2017–2031

            14.3.1. Dialysate & Replacement Fluids

            14.3.2. Disposables

                14.3.2.1. Bloodline Sets

                14.3.2.2. Hemofilters

                14.3.2.3. Other Disposables

            14.3.3. Systems

        14.4. Market Value Forecast, by Therapy, 2017–2031

            14.4.1. Renal

            14.4.2. Non-renal

            14.4.3. Combination

        14.5. Market Value Forecast, by End-user, 2017–2031

            14.5.1. Hospitals

            14.5.2. Clinics

            14.5.3. Others

        14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.6.1. Brazil

            14.6.2. Mexico

            14.6.3. Rest of Latin America

        14.7. Market Attractiveness Analysis

            14.7.1. By Mode

            14.7.2. By Product

            14.7.3. By Therapy

            14.7.4. By End-user

            14.7.5. By Country/Sub-region

    15. Middle East & Africa Continuous Renal Replacement Therapy Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Mode, 2017–2031

            15.2.1. Slow Continuous Ultrafiltration (SCUF)

            15.2.2. Continuous Venovenous Hemofiltration (CVVHF)

            15.2.3. Continuous Venovenous Hemodialysis (CVVHD)

            15.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)

        15.3. Market Value Forecast, by Product, 2017–2031

            15.3.1. Dialysate & Replacement Fluids

            15.3.2. Disposables

                15.3.2.1. Bloodline Sets

                15.3.2.2. Hemofilters

                15.3.2.3. Other Disposables

            15.3.3. Systems

        15.4. Market Value Forecast, by Therapy, 2017–2031

            15.4.1. Renal

            15.4.2. Non-renal

            15.4.3. Combination

        15.5. Market Value Forecast, by End-user, 2017–2031

            15.5.1. Hospitals

            15.5.2. Clinics

            15.5.3. Others

        15.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            15.6.1. GCC Countries

            15.6.2. South Africa

            15.6.3. Rest of Middle East & Africa

        15.7. Market Attractiveness Analysis

            15.7.1. By Mode

            15.7.2. By Product

            15.7.3. By Therapy

            15.7.4. By End-user

            15.7.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player – Competition Matrix (By Tier and Size of companies)

        16.2. Market Position By Company (2021)

        16.3. Company Profiles

            16.3.1. Baxter International, Inc.

                16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.1.2. Product Portfolio

                16.3.1.3. SWOT Analysis

                16.3.1.4. Strategic Overview

            16.3.2. Nipro Corporation

                16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.2.2. Product Portfolio

                16.3.2.3. SWOT Analysis

                16.3.2.4. Strategic Overview

            16.3.3. Asahi Kasei Corporation

                16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.3.2. Product Portfolio

                16.3.3.3. SWOT Analysis

                16.3.3.4. Strategic Overview

            16.3.4. B. Braun Melsungen AG

                16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.4.2. Product Portfolio

                16.3.4.3. SWOT Analysis

                16.3.4.4. Strategic Overview

            16.3.5. Medica SPA

                16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.5.2. Product Portfolio

                16.3.5.3. SWOT Analysis

                16.3.5.4. Strategic Overview

            16.3.6. INFOMED SA

                16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.6.2. Product Portfolio

                16.3.6.3. SWOT Analysis

                16.3.6.4. Strategic Overview

            16.3.7. Medtronic

                16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.7.2. Product Portfolio

                16.3.7.3. SWOT Analysis

                16.3.7.4. Strategic Overview

            16.3.8. Toray Medical Company Limited (Toray Industries, Inc.)

                16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.8.2. Product Portfolio

                16.3.8.3. SWOT Analysis

                16.3.8.4. Strategic Overview

    List of Tables

    Table 01: Opportunity Map, by Mode, 2021

    Table 02: Market Opportunity Map, by Product Type, 2021

    Table 03: Opportunity Map, by Therapy, 2021

    Table 04: Opportunity Map, by End-user, 2021

    Table 05: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Mode, 2017–2031

    Table 06: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

    Table 07: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Disposables, 2017–2031

    Table 08: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Therapy, 2017–2031

    Table 09: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

    Table 10: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Region, 2017–2031

    Table 11: North America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Mode, 2017–2031

    Table 12: North America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

    Table 13: North America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Disposables, 2017–2031

    Table 14: North America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Therapy, 2017–2031

    Table 15: North America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

    Table 16: North America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Country, 2017–2031

    Table 17: Europe Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Mode, 2017–2031

    Table 18: Europe Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

    Table 19: Europe Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Disposables, 2017–2031

    Table 20: Europe Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Therapy, 2017–2031

    Table 21: Europe Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

    Table 22: Europe Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 23: Asia Pacific Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Mode, 2017–2031

    Table 24: Asia Pacific Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

    Table 25: Asia Pacific Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Disposables, 2017–2031

    Table 26: Asia Pacific Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Therapy, 2017–2031

    Table 27: Asia Pacific Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

    Table 28: Asia Pacific Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 29: Latin America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Mode, 2017–2031

    Table 30: Latin America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

    Table 31: Latin America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Disposables, 2017–2031

    Table 32: Latin America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Therapy, 2017–2031

    Table 33: Latin America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

    Table 34: Latin America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 35: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Mode, 2017–2031

    Table 36: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

    Table 37: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Disposables, 2017–2031

    Table 38: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Therapy, 2017–2031

    Table 39: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

    Table 40: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    List of Figures

    Figure 01: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) and End-user, by Region, 2021 and 2031

    Figure 02: Global Continuous Renal Replacement Therapy Market Share Analysis, by Region, 2021

    Figure 03: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, 2017–2031

    Figure 04: Global Continuous Renal Replacement Therapy Market Revenue Share, by Mode, 2021

    Figure 05: Global Continuous Renal Replacement Therapy Market Revenue Share, by Product, 2021

    Figure 06: Global Continuous Renal Replacement Therapy Market Revenue Share, by Therapy, 2021

    Figure 07: Global Continuous Renal Replacement Therapy Market Revenue Share, by End-user, 2021

    Figure 08: Global Continuous Renal Replacement Therapy Market Revenue Share, by Region, 2021

    Figure 09: Global Continuous Renal Replacement Therapy Market Revenue Share, by Mode, 2021 and 2031

    Figure 10: Global Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Mode, 2022–2031

    Figure 11: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by SCUF, 2017–2031

    Figure 12: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by CVVH, 2017–2031

    Figure 13: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by CVVHD, 2017–2031

    Figure 14: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by CVVHDF, 2017–2031

    Figure 15: Global Continuous Renal Replacement Therapy Market Revenue Share Analysis, by Product, 2021 and 2031

    Figure 16: Global Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Product, 2022–2031

    Figure 17 A: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Dialysate & Replacement Fluids, 2017–2031

    Figure 17 B: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Disposables, 2017–2031

    Figure 18: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Systems, 2017–2031

    Figure 19: Global Continuous Renal Replacement Therapy Market Revenue Share Analysis, by Therapy, 2021 and 2031

    Figure 20: Global Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

    Figure 21: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Renal, 2022–2031

    Figure 22: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) ) Forecast , by Non-renal, 2022–2031

    Figure 23: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Combination, 2022–2031

    Figure 24: Global Continuous Renal Replacement Therapy Market Revenue Share, by End-user, 2021 and 2031

    Figure 25: Global Continuous Renal Replacement Therapy Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 26: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) ) Forecast and Y-o-Y Growth (%), by Hospitals, 2022–2031

    Figure 27: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) ) Forecast and Y-o-Y Growth (%), by Clinics, 2022–2031

    Figure 28: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2022–2031

    Figure 29: Global Continuous Renal Replacement Therapy Market Revenue Share, by Region, 2021 and 2031

    Figure 30: Global Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Region, 2022–2031

    Figure 31: North America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

    Figure 32: North America Continuous Renal Replacement Therapy Market Revenue Share, by Mode, 2021 and 2031

    Figure 33: North America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Mode, 2022–2031

    Figure 34: North America Continuous Renal Replacement Therapy Market Revenue Share, by Product, 2021 and 2031

    Figure 35: North America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Product, 2022–2031

    Figure 36: North America Continuous Renal Replacement Therapy Market Revenue Share, by Therapy, 2021 and 2031

    Figure 37: North America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

    Figure 38: North America Continuous Renal Replacement Therapy Market Revenue Share, by End-user, 2021 and 2031

    Figure 39: North America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 40: North America Continuous Renal Replacement Therapy Market Revenue Share, by Country, 2021 and 2031

    Figure 41: North America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Country, 2022–2031

    Figure 42: Europe Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

    Figure 43: Europe Continuous Renal Replacement Therapy Market Revenue Share, by Mode, 2021 and 2031

    Figure 44: Europe Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Mode, 2022–2031

    Figure 45: Europe Continuous Renal Replacement Therapy Market Revenue Share, by Product, 2021 and 2031

    Figure 46: Europe Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Product, 2022–2031

    Figure 47: Europe Continuous Renal Replacement Therapy Market Revenue Share, by Therapy, 2021 and 2031

    Figure 48: Europe Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

    Figure 49: Europe Continuous Renal Replacement Therapy Market Revenue Share, by End-user, 2021 and 2031

    Figure 50: Europe Continuous Renal Replacement Therapy Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 51: Europe Continuous Renal Replacement Therapy Market Revenue Share, by Country/Sub-region, 2021 and 2031

    Figure 52: Europe Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 53: Asia Pacific Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

    Figure 54: Asia Pacific Continuous Renal Replacement Therapy Market Revenue Share, by Mode, 2021 and 2031

    Figure 55: Asia Pacific Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Mode, 2022–2031

    Figure 56: Asia Pacific Continuous Renal Replacement Therapy Market Revenue Share, by Product, 2021 and 2031

    Figure 57: Asia Pacific Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Product, 2022–2031

    Figure 58: Asia Pacific Continuous Renal Replacement Therapy Market Revenue Share, by Therapy, 2021 and 2031

    Figure 59: Asia Pacific Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

    Figure 60: Asia Pacific Continuous Renal Replacement Therapy Market Revenue Share, by End-user, 2021 and 2031

    Figure 61: Asia Pacific Continuous Renal Replacement Therapy Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 62: Asia Pacific Continuous Renal Replacement Therapy Market Revenue Share, by Country/Sub-region, 2021 and 2031

    Figure 63: Asia Pacific Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 64: Latin America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

    Figure 65: Latin America Continuous Renal Replacement Therapy Market Revenue Share, by Mode, 2021 and 2031

    Figure 66: Latin America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Mode, 2022–2031

    Figure 67: Latin America Continuous Renal Replacement Therapy Market Revenue Share, by Product, 2021 and 2031

    Figure 68: Latin America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Product, 2022–2031

    Figure 69: Latin America Continuous Renal Replacement Therapy Market Revenue Share, by Therapy, 2021 and 2031

    Figure 70: Latin America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

    Figure 71: Latin America Continuous Renal Replacement Therapy Market Revenue Share, by End-user, 2021 and 2031

    Figure 72: Latin America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 73: Latin America Continuous Renal Replacement Therapy Market Revenue Share, by Country/Sub-region, 2021 and 2031

    Figure 74: Latin America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 75: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

    Figure 76: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue Share, by Mode, 2021 and 2031

    Figure 77: Middle East & Africa Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Mode, 2022–2031

    Figure 78: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue Share, by Product, 2021 and 2031

    Figure 79: Middle East & Africa Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Product, 2022–2031

    Figure 80: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue Share, by Therapy, 2021 and 2031

    Figure 81: Middle East & Africa Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

    Figure 82: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue Share, by End-user, 2021 and 2031

    Figure 83: Middle East & Africa Continuous Renal Replacement Therapy Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 84: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue Share, by Country/Sub-region, 2021 and 2031

    Figure 85: Middle East & Africa Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031

Copyright © Transparency Market Research, Inc. All Rights reserved